Exclusivamente para investigacin cientfica
Unlike growth factors requiring carriers for delivery, BPC-157 works effectively on its own
Owing to its unique structure and mode of action, SS-31 demonstrates potential therapeutic value across cardiovascular diseases, neurodegenerative disorders, kidney injury, and myopathies associated with mitochondrial dysfunction 1-6
Supports vascularity and blood flow: Enhances blood circulation to injured areas, ensuring efficient delivery of nutrients and oxygen for faster recovery
247 The primary action often occurs through indirect mechanisms, such as insulin and somatostatin
Additionally, the gene changes include upregulation of cancer-protective genes and DNA repair mechanisms, suggesting a net protective effect